Martha Holtje

Array ( [id] => 6760772 [patent_doc_number] => 20030124133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'RECEPTOR TYROSINE KINASE WITH A DISCOIDIN-TYPE BINDING DOMAIN' [patent_app_type] => new [patent_app_number] => 09/140378 [patent_app_country] => US [patent_app_date] => 1998-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5191 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124133.pdf [firstpage_image] =>[orig_patent_app_number] => 09140378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4298040 [patent_doc_number] => 06197930 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'Adipocyte-specific protein homologs' [patent_app_type] => 1 [patent_app_number] => 9/140804 [patent_app_country] => US [patent_app_date] => 1998-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 28978 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197930.pdf [firstpage_image] =>[orig_patent_app_number] => 140804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1544784 [patent_doc_number] => 06444440 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-03 [patent_title] => 'Vanilloid receptor-2' [patent_app_type] => B1 [patent_app_number] => 09/132316 [patent_app_country] => US [patent_app_date] => 1998-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 44513 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/444/06444440.pdf [firstpage_image] =>[orig_patent_app_number] => 09132316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4420295 [patent_doc_number] => 06194558 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'DNA encoding human monocyte-macrophage apolipoprotein B receptor gene and protein' [patent_app_type] => 1 [patent_app_number] => 9/130242 [patent_app_country] => US [patent_app_date] => 1998-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 29 [patent_no_of_words] => 23554 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194558.pdf [firstpage_image] =>[orig_patent_app_number] => 130242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1473962 [patent_doc_number] => 06387638 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Heregulin variants' [patent_app_type] => B1 [patent_app_number] => 09/101544 [patent_app_country] => US [patent_app_date] => 1998-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 32006 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 595 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387638.pdf [firstpage_image] =>[orig_patent_app_number] => 09101544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1479505 [patent_doc_number] => 06451986 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Site specific protein modification' [patent_app_type] => B1 [patent_app_number] => 09/102530 [patent_app_country] => US [patent_app_date] => 1998-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11145 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451986.pdf [firstpage_image] =>[orig_patent_app_number] => 09102530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6765647 [patent_doc_number] => 20030100047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'TESTIS-SPECIFIC RECEPTOR' [patent_app_type] => new [patent_app_number] => 09/090867 [patent_app_country] => US [patent_app_date] => 1998-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12197 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100047.pdf [firstpage_image] =>[orig_patent_app_number] => 09090867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6613573 [patent_doc_number] => 20020015967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => 'FUNCTIONAL EXPRESSION OF ADENOSINE RECEPTORS IN YEAST' [patent_app_type] => new [patent_app_number] => 09/088985 [patent_app_country] => US [patent_app_date] => 1998-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27689 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20020015967.pdf [firstpage_image] =>[orig_patent_app_number] => 09088985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1454649 [patent_doc_number] => 06462188 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-08 [patent_title] => 'Human 5-HT3 receptor' [patent_app_type] => B1 [patent_app_number] => 09/061154 [patent_app_country] => US [patent_app_date] => 1998-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 7148 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/462/06462188.pdf [firstpage_image] =>[orig_patent_app_number] => 09061154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1315102 [patent_doc_number] => 06607906 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-19 [patent_title] => 'Heterologous G protein coupled receptors expressed in yeast, their fusion with G proteins and use thereof in bioassay' [patent_app_type] => B1 [patent_app_number] => 09/057473 [patent_app_country] => US [patent_app_date] => 1998-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 44 [patent_no_of_words] => 25429 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/607/06607906.pdf [firstpage_image] =>[orig_patent_app_number] => 09057473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1210271 [patent_doc_number] => 06713609 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-30 [patent_title] => 'Monoclonal antibodies to type I interferon receptor' [patent_app_type] => B1 [patent_app_number] => 09/056461 [patent_app_country] => US [patent_app_date] => 1998-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 16 [patent_no_of_words] => 36948 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713609.pdf [firstpage_image] =>[orig_patent_app_number] => 09056461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1411389 [patent_doc_number] => 06528493 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-03-04 [patent_title] => 'Screening methods for identifying modulators of proliferation and differentiation of bone cells' [patent_app_type] => B2 [patent_app_number] => 09/045585 [patent_app_country] => US [patent_app_date] => 1998-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7002 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528493.pdf [firstpage_image] =>[orig_patent_app_number] => 09045585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4393511 [patent_doc_number] => 06297028 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-02 [patent_title] => 'IL-2R-associated polypeptide and DNA molecules coding therefor' [patent_app_type] => 1 [patent_app_number] => 8/860656 [patent_app_country] => US [patent_app_date] => 1998-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12482 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/297/06297028.pdf [firstpage_image] =>[orig_patent_app_number] => 860656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4372524 [patent_doc_number] => 06303121 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Method of using human receptor protein 4-1BB' [patent_app_type] => 1 [patent_app_number] => 9/007097 [patent_app_country] => US [patent_app_date] => 1998-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 8 [patent_no_of_words] => 23951 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303121.pdf [firstpage_image] =>[orig_patent_app_number] => 007097 [rel_patent_id] =>[rel_patent_doc_number] =>)